Across TCGA pan-cancer cohorts, GANC mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GANC data layer compared with 27 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher GANC mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated GANC expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

HNSC, PDAC, and UCEC are the cancer types where GANC mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	1.000	0.942	.023	11	view →
PDAC	DFS	Median	IV	0.250	0.934	.024	6	view →
UCEC	DFS	Quartile	III,IV	0.270	0.848	.041	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: GANC tumor-vs-normal RNA expression · all GANC data types